<?xml version="1.0" encoding="UTF-8"?>
<p>Sequences encoding an N-terminal hexa-histidine (6His) tag upstream of human DDX3X (residues 1–580) or the catalytically inactive DDX3X mutant K230E (residues 1–580) [
 <xref rid="B6-cells-09-00170" ref-type="bibr">6</xref>] were cloned into the pCOLD expression vector (Takara Bio, Kusatsu, Japan). The 6His-DDX3X and the pCOLD-6His-DDX3X K230E mutant were expressed separately in 
 <italic>Escherischia coli</italic> (
 <italic>E. coli</italic>) BL21 (DE3) cells at 16 °C following induction at OD
 <sub>600nm</sub> = 0.6 with 1 mM isopropyl 1-thiol-β-D-galactopyranoside (IPTG) and harvested 20 h post-induction prior to resuspension in lysis buffer (20 mM Tris-Cl pH 8.0, 500 mM NaCl, 20% (
 <italic>v</italic>/
 <italic>v</italic>) glycerol, 0.5 mM TCEP, 10 mM imidazole, supplemented with 1 mg/mL lysozyme, 0.1% (
 <italic>v</italic>/
 <italic>v</italic>) Tween-20 and cOmplete protease inhibitor tablets (Roche, Basel, Switzerland)). Proteins were extracted by sonication and clarified prior to purification using Ni-NTA Superflow resin (Qiagen, Hilden, Germany). Resin was washed with lysis buffer + 20 mM imidazole and 1% (
 <italic>v</italic>/
 <italic>v</italic>) Tween-20 and eluted in buffer containing 300 mM imidazole. Eluate was then applied to a Superdex 200 16/60 gel filtration column equilibrated in 20 mM Tris-Cl pH 8.0, 500 mM NaCl, 20% (
 <italic>v</italic>/
 <italic>v</italic>) glycerol, and 0.5 mM TCEP. Protein fractions containing DDX3X were pooled and protein purity determined by SDS-PAGE (
 <xref ref-type="fig" rid="cells-09-00170-f001">Figure 1</xref>A).
</p>
